# A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

> **NCT00667342** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 43 (actual)

## Conditions studied

- Osteosarcoma
- Malignant Fibrous Histiocytoma (MFH) of Bone

## Interventions

- **BIOLOGICAL:** Bevacizumab
- **DRUG:** Cisplatin
- **DRUG:** Doxorubicin
- **DRUG:** Methotrexate
- **DRUG:** Ifosfamide
- **DRUG:** etoposide
- **PROCEDURE:** Surgery
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00667342
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-03
- **Primary completion:** 2014-08
- **Final completion:** 2017-08
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667342, "A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00667342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*